-
-
Call more information
660-596-2224 -
Author: Patsy Newitt Becker’s ASC Review Four anesthesiologists joined Becker’s to discuss how they expect the anesthesia provider shortage will disrupt care in the next five years. Editor’s note: These responses were edited lightly for clarity and length. Thomas Durick, MD. Anesthesiologist at The Ohio State University Wexner Medical Center (Columbus): As private equity firms keep buying up […]
Read MoreAuthor: Dave Muoio Fierce Healthcare Two of Trinity Health’s affiliate hospitals mounted lawsuits against a large anesthesia group alleging that noncompete and non-solicitation clauses included in its providers’ contracts restrict competition, drive high prices and “compel” the hospital to accept their terms. Holy Cross Hospital and St. Joseph’s Hospital Health Center filed the parallel complaints […]
Read MoreAuthors: Pooja Parameshwar, MD et al Anesthesiology Newly Published on February 2024. Background Neuraxial analgesia provides effective pain relief during labor. However, it is unclear whether neuraxial analgesia prevalence differs across US hospitals. Our aim was to assess hospital variation in neuraxial analgesia prevalence in California. Methods A retrospective cross-sectional study analyzed birthing patients who underwent […]
Read MoreAuthor: Mary Dale Peterson, MD, MSHCA, FACHE, FASA ASA Monitor March 2024, Vol. 88, 29. I want to thank Dr. Yu et al. for a thought-provoking article on page 28 looking at possible causes for our workforce imbalance. While the hypothesis from Yu et al. that published workforce projections influence medical students’ decision-making is plausible, there […]
Read MoreASA Monitor March 2024, Vol. 88, 12. Which of the following opioids has significant active metabolites that accumulate in patients with renal failure? □ (A) Fentanyl □ (B) Morphine □ (C) Hydromorphone Renal failure affects the pharmacology of all opioids, but especially morphine and meperidine. Morphine is metabolized into two water-soluble metabolites in the liver and kidney: morphine-3-glucuronide (M3G) […]
Read MoreAuthor: Daniel Campos, MD, MPH, FASA ASA Monitor March 2024, Vol. 88, 18–19. I have just concluded five years of chairing the ASA Committee on Anesthesia Care Team (CACT), a highlight of my time as an active ASA member. A group of passionate, motivated, and knowledgeable individuals, the CACT is committed to the highest quality of […]
Read MoreBy Dave Muoio Fierce Heathcare Influential senators held Department of Health and Human Services Secretary Xavier Becerra’s feet to the fire on Thursday, urging him and his department to deliver prompt relief and maintain pressure on industry to invest in cybersecurity. (Senate Finance Committee) Leading senators want the Department of Health and Human Services (HHS), insurers […]
Read MoreAuthors: Lena Scotto, MD; Natalie Moreland, MD ASA Monitor March 2024, Vol. 88, 35. Individuals over the age of 65 make up the largest proportion of patients seeking surgical care. Advanced age and underlying cognitive disorders are risk factors for the development of cognitive impairment, the most common complication in this age group. Perioperative neurocognitive disorders (PNDs) […]
Read MoreAuthors: Cathlin Bowman-Young, MBA; Matthew T. Popovich, PhD ASA Monitor March 2024, Vol. 88, 24–25. As anesthesiologists and their groups are wrapping up the 2023 Merit-based Incentive Payment System (MIPS) reporting year, we realize that those same groups are determining their MIPS 2024 quality measures and improvement activities to report. We take a moment to share with […]
Read MoreASA Monitor March 2024, Vol. 88, 14. CD8+ T cell activity could improve effectiveness of HIV vaccine A study funded by the National Institute of Allergy and Infectious Diseases suggests that an effective HIV vaccine might need to stimulate robust responses from CD8+ T cells to protect against HIV acquisition. In HIV infection, the virus damages […]
Read More